The conference will give an overview of the recent regulatory developments in the Eurasian Union, discuss the harmonisation of national regulations and the implications of recent changes for the regulatory and product approval strategies in the region, as well as facilitate an open dialog between regulatory officials and the industry

30
speakers
2
days
20
partners
100
participiants

Programme 2018

Focus

An up-to-date overview of the Eurasian pharmaceutical regulatory and business environment

Open Discussions

Interactive sessions featuring representatives of regulators and the industry

Special Focus

API regulation; Pricing regulation; Patent laws and protection of IP; Pharmacovigilance; Labelling of medical products

 

Key topics

Improving quality control, cooperation between registration and quality control organs
Recognition of the common harmonised procedures between national regulators
Registration of medical products; the future of eCTD
Pharmacovigilance and the data collection system in the EAEU
Protection of intellectual property rights in the EAEU
Current Issues of Compliance in the EAEU

Partners

Associate partner
Media partner

Venue